Ebrator Biochemicals Inc.

Ebrator Biochemicals Inc. is a biotechnology and pharmaceutical company that offers a wide range of life science and fine chemical raw materials to scientists globally. Their product portfolio includes enhanced quality documentation such as Certificates of Origin, BSE/TSE Statements, and GMO Statements. The company caters to various sectors including pharma, diagnostics, biotech, healthcare, governmental sector, CMO, CRO, industrial companies, academic, and research institutions. Established in 2018 and headquartered in the United States, Ebrator Biochemicals prides itself on its ability to scale from benchtop to bulk production to meet customer requirements and enhance satisfaction. The company also offers custom synthesis of organic compounds in small scale (milligram) to bulk quantities (kilogram) at competitive prices. Additionally, customized packaging, container types, labeling, and other fill requirements are available upon request. Their key products include biochemicals for life science research, fine chemicals and intermediates, impurities, analytical reagents, qPCR, biological stains and dyes, indicators, DNA cloning, as well as all impurities of Prostaglandin such as Latanoprost, Travoprost, Bimatoprost, and Carboprost. Ebrator Biochemicals Inc. presents a promising opportunity for investment with its innovative product range and commitment to quality and customer satisfaction.